WB | 1/500-1/1000 | Human,Mouse,Rat |
IF | 1/20 | Human,Mouse,Rat |
IHC | 1/50-1/100 | Human,Mouse,Rat |
ICC | 1/50-1/200 | Human,Mouse,Rat |
FCM | 咨询技术 | Human,Mouse,Rat |
Elisa | 咨询技术 | Human,Mouse,Rat |
Aliases | CCT2; 99D8.1; CCTB; T-complex protein 1 subunit beta; TCP-1-beta; CCT-beta |
Entrez GeneID | 10576 |
WB Predicted band size | Calculated MW: 57 kDa; Observed MW: 57 kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human,Mouse,Rat |
Immunogen | A synthetic peptide of human CCT2 |
Formulation | Purified antibody in TBS with 0.05% sodium azide,0.05%BSA and 50% glycerol. |
+ +
以下是关于CCT2抗体的3篇参考文献及其摘要概括:
---
1. **文献名称**: *CCT2 is an aggresome formation regulator modulating pancreatic carcinogenesis*
**作者**: Chen Y, et al.
**摘要**: 研究利用CCT2特异性抗体,发现CCT2通过调控异常蛋白聚集体的形成促进胰腺癌细胞增殖和转移,提示其作为治疗靶点的潜力。
2. **文献名称**: *Targeting CCT2 by its inhibitor AC-3265 for the treatment of triple-negative breast cancer*
**作者**: Zhang L, et al.
**摘要**: 通过CCT2抗体验证AC-3265抑制剂对CCT2蛋白的靶向作用,证明其可抑制三阴性乳腺癌细胞的生长并诱导凋亡。
3. **文献名称**: *CCT2 interacts with β-catenin to drive stemness in colorectal cancer*
**作者**: Wang H, et al.
**摘要**: 采用CCT2抗体进行免疫共沉淀实验,揭示CCT2与β-catenin互作维持结直肠癌干性,为抗体阻断治疗策略提供依据。
---
**说明**:以上文献均为虚拟示例,实际研究中建议通过PubMed或Web of Science检索关键词“CCT2 antibody”或“CCT2 inhibitor”获取真实文献。
×